EcoR1 Capital LLC 13D and 13G filings for SpringWorks Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 6:41 pm Sale | 2023-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX | EcoR1 Capital LLC | 0 0.000% | -3,460,208 (Position Closed) | Filing |
| 2022-09-19 08:27 am Purchase | 2022-09-07 | 13G | SpringWorks Therapeutics, Inc. SWTX | EcoR1 Capital LLC | 3,460,208 5.500% | 3,460,208 (New Position) | Filing |